You have accessJournal of UrologyStone Disease: New Technology/SWL, Ureteroscopic or Percutaneous Stone Removal III1 Apr 20121835 EQUIPMENT USE DURING URETEROSCOPY: IS THERE A DIFFERENCE BETWEEN TERTIARY CARE CENTERS AND COMMUNITY HOSPITALS? Justin Friedlander, Bin Xu, Zhamshid Okhunov, Cristina Sison, Brian Duty, Nikhil Waingankar, Zeph Okeke, and Arthur Smith Justin FriedlanderJustin Friedlander New Hyde Park, NY More articles by this author , Bin XuBin Xu Shanghai, China, People's Republic of More articles by this author , Zhamshid OkhunovZhamshid Okhunov New Hyde Park, NY More articles by this author , Cristina SisonCristina Sison Manhasset, NY More articles by this author , Brian DutyBrian Duty New Hyde Park, NY More articles by this author , Nikhil WaingankarNikhil Waingankar New Hyde Park, NY More articles by this author , Zeph OkekeZeph Okeke New Hyde Park, NY More articles by this author , and Arthur SmithArthur Smith New Hyde Park, NY More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2012.02.1923AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES We sought to investigate whether there exists a difference in disposable equipment usage during ureteroscopy between tertiary (TH) and community hospitals (CH). METHODS We performed a retrospective review of ureteroscopy procedures for calculus disease at two tertiary care centers and two community hospitals from January through October 2010. Cases were identified by procedural code for ureteral calculus. Variables under examination included patient demographics, surgeon training level, hospital setting, clinical stone characteristics, instruments and materials used, and clinical outcomes. Cost data for disposable equipment was obtained from health system billing records. Mann-Whitney and Chi-square tests were used to analyze continuous and categorical variables, respectively. Multivariable regression analysis was performed. RESULTS Of the 318 procedures evaluated, 80.8% (257) were performed at TH versus 19.2% (61) performed at CH. There was no difference in mean stone size, procedures treating more than 1 stone, mean operating room time, use of more than 1 wire during a procedure, or mean disposable equipment cost (TH 861.30 vs CH 802.30, p=0.91) between the two groups. Significant differences were found between TH and CH for Holmium laser use (65.4% vs 49.2%, p=0.03), balloon dilator use (31.5% vs 73.8%, p<0.0001), ureteral access sheath use (27.6% vs 4.9%, p<0.0001), dual lumen catheter use (22.2% vs 1.6%, p<0.0001), use of stone baskets (95.7% vs 86.9%, p=0.015), and the presence of a stent in place prior to definitive ureteroscopy (26.9% vs 14.8%, p=0.049). The stone-free rate for TH was 91.4% versus 86.9% at CH, this was not statistically significant (p=0.32). Multivariable regression analysis revealed that stone size (p <0.001) and the presence of a stent at the time of ureteroscopy (p=0.0006) were significantly associated with cost of disposable equipment charged. CONCLUSIONS We found no difference in cost of disposable equipment used during ureteroscopy between TH and CH. TH demonstrated more frequent use of the Holmium laser, ureteral access sheaths, dual lumen catheters, and stone baskets, whereas CH demonstrated more frequent use of ureteral balloon dilation. Stone-free status was greater at TH than CH; however, this did not reach statistical significance. Table 1. Descriptive Statistics and Equipment Usage Tertiary Care Hospitals (TH) Community Hospitals (CH) p-value Mean stone size (in mm) 6.48 6.41 0.98 Patients with stone size ≥ 7 mm 60.3%(155/257) 62.3%(38/61) 0.88 More than 1 stone treated 24.9%(64/257) 21.3%(13/61) 0.62 Stone location Kidney 10.1%(26/257) 1.6%(1/61) Ureter 85.6%(220/257) 93.4%(57/61) Both kidney and ureter 4.3%(11/257) 4.9%(3/61) Mean OR time (in minutes) 47.22 45.90 0.95 Mean disposable equipment cost (in US dollars) 861.30 802.30 0.91 Use of more than 1 wire 53.3%(137/257) 49.2%(30/61) 0.57 Holmium laser use 65.4%(168/257) 49.2%(30/61) 0.03 Balloon dilator use 31.5%(81/257) 73.8%(45/61) <0.0001 Ureteral access sheath use 27.6%(71/257) 4.9%(3/61) <0.0001 Dual lumen catheter use 22.2%(57/257) 1.6%(1/61) <0.0001 Anti-retropulsion device use 3.9%(10/257) 8.2%(5/61) 0.18 Stone basket use 95.7%(246/257) 86.9%(53/61) 0.015 Stent in place before ureteroscopy 26.9%(69/257) 14.8%(9/61) 0.049 Stent after ureteroscopy 91.4%(235/257) 96.7%(59/61) 0.28 © 2012 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 187Issue 4SApril 2012Page: e742 Peer Review Report Advertisement Copyright & Permissions© 2012 by American Urological Association Education and Research, Inc.MetricsAuthor Information Justin Friedlander New Hyde Park, NY More articles by this author Bin Xu Shanghai, China, People's Republic of More articles by this author Zhamshid Okhunov New Hyde Park, NY More articles by this author Cristina Sison Manhasset, NY More articles by this author Brian Duty New Hyde Park, NY More articles by this author Nikhil Waingankar New Hyde Park, NY More articles by this author Zeph Okeke New Hyde Park, NY More articles by this author Arthur Smith New Hyde Park, NY More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...
Read full abstract